Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Vet Med Sci ; 79(9): 1596-1602, 2017 Sep 29.
Article in English | MEDLINE | ID: mdl-28740028

ABSTRACT

10-Hydroxy-2-decenoic acid (10H2DA) is a fatty acid found in royal jelly (RJ). In healthy mice, it activates 5'-AMP-activated protein kinase (AMPK) and increases glucose transporter 4 (GLUT4) translocation. Therefore, we examined whether 10H2DA has a potential therapeutic effect against type 2 diabetes in obese/diabetic KK-Ay mice. 10H2DA (3 mg/kg body weight) was administered to female KK-Ay mice for 4 weeks by oral gavage. Phenotypes for body weight, plasma glucose by oral glucose tolerance test and insulin levels were measured. mRNA and protein levels were determined using qRT-PCR and Western blot analyses, respectively. Long-term administration of 10H2DA significantly improved hyperglycemia and insulin resistance in KK-Ay mice, but did not prevent obesity. 10H2DA increased the expression of phosphorylated AMPK (pAMPK) protein in skeletal muscles; however, this expression did not correlate with increased GLUT4 translocation. Furthermore, 10H2DA neither enhanced the expression of adiponectin receptor mRNA nor activated the insulin signaling cascade, such as GSK-3ß phosphorylation, in the liver. We found that 10H2DA-treated mice had a significant increase in the expression of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (Pgc-1α) mRNA in skeletal muscles compared with non-treated group (P=0.0024). These findings suggest that 10H2DA is involved in the improvement of type 2 diabetes, at least in part via activation of Pgc-1α expression, but does not prevent obesity.


Subject(s)
Fatty Acids, Monounsaturated/pharmacology , Hyperglycemia/drug therapy , Insulin Resistance , Liver/enzymology , Obesity/drug therapy , Adiponectin/classification , Adiponectin/genetics , Adiponectin/metabolism , Adipose Tissue/metabolism , Animals , Gene Expression Regulation, Enzymologic/drug effects , Glucose Tolerance Test , Homeostasis , Liver/drug effects , Mice , Mice, Inbred Strains , RNA, Messenger/genetics , RNA, Messenger/metabolism
2.
Gen Comp Endocrinol ; 168(3): 307-11, 2010 Sep 15.
Article in English | MEDLINE | ID: mdl-20553720

ABSTRACT

Adiponectin is a novel adipocyte-derived hormone with low circulating concentrations and/or mRNA expression in obesity and non-alcoholic fatty liver disease (NAFLD). The adiponectin mRNA of several Carnivora species was sequenced to enable further gene expression studies in this clade with potential experimental species to examine the connections of hypoadiponectinemia to hepatic lipidosis. In addition, adiponectin mRNA expression was studied in the retroperitoneal fat of the American mink (Neovison vison), as hepatic lipidosis with close similarities to NAFLD can be rapidly induced to the species by fasting. The mRNA expression was determined after overnight-7d of food deprivation and 28d of re-feeding and correlated to the liver fat %. The homologies between the determined carnivoran mRNA sequences and that of the domestic dog were 92.2-99.1%. As the mRNA expression was not affected by short-term fasting and did not correlate with the liver fat %, there seems to be no clear connection between adiponectin and the development of lipidosis in the American mink. In the future, the obtained sequences can be utilized in further studies of adiponectin expression in comparative endocrinology.


Subject(s)
Adiponectin/genetics , Fatty Liver/metabolism , RNA, Messenger/genetics , Adiponectin/chemistry , Adiponectin/classification , Amino Acid Sequence , Animals , Carnivora , Cattle , Fatty Liver/genetics , Molecular Sequence Data , Phylogeny , Platypus , Sequence Homology, Amino Acid , Swine
3.
Prog Neuropsychopharmacol Biol Psychiatry ; 32(1): 124-7, 2008 Jan 01.
Article in English | MEDLINE | ID: mdl-17761380

ABSTRACT

Adiponectin is an adipocyte-specific secretory protein that circulates in serum as three oligomeric complexes known as the high, medium and low molecular weight form (HMW, MMW and LMW). HMW adiponectin has been suggested to be a better predictor of metabolic variables, and it was recently reported that the ratio of HMW to total adiponectin or to LMW, not the absolute amount of plasma adiponectin, might be crucial in determining insulin sensitivity. Insulin resistance (IR) is considered to be a primary component of vascular risk factors. Although the association of depression with atherosclerotic vascular diseases has been well documented, the contribution of IR to the evolution and progression of depression-associated vascular morbidity and mortality remains unknown. The current preliminary study showed that the ratio of HMW to total adiponectin or to LMW, not the absolute amount of plasma adiponectin, was negatively associated with depression severity in healthy elderly subjects without metabolic syndrome. This pilot study supports a promising role of adiponectin multimer distribution for clarifying the pathophysiological mechanism by which depression is associated with increased risk for IR, leading to cardiovascular disease, metabolic syndrome or type 2 diabetes.


Subject(s)
Adiponectin/blood , Adiponectin/classification , Depression/blood , Geriatrics , Statistics as Topic , Aged , Analysis of Variance , Female , Humans , Male , Middle Aged , Molecular Weight , Severity of Illness Index
4.
Cell Signal ; 18(6): 761-70, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16386877

ABSTRACT

The C1q-globular domain (gC1qD) is a highly conserved oligomerization motif that distinguishes a superfamily of proteins, which includes circulating factors like C1q (the first component of the complement cascade) and adiponectin. The compact structure resulting from gC1qD trimerization is well known for its versatility in establishing highly specific interactions with different ligands. Among the many binding targets are a large number of extracellular membrane-associated receptors involved in cell development, apoptosis, and immunological processes. Interestingly, proteins interacting with the prototypical globular domain of C1q have been described also inside the cell where they were shown to recognize signal transducers such as G protein coupled receptors and their downstream effectors. Afterward, it was shown that variants of the gC1qD have been adopted by intracellular proteins involved in signal transduction. This review summarizes the evidence supporting the presence of the gC1qD inside the cell and explores the possibility that the domain might play novel signaling functions in this context, such as determining highly specific protein-protein interactions aimed to organize signaling complexes on the cytosolic side of cellular membranes.


Subject(s)
Complement C1q/physiology , Signal Transduction , Adiponectin/classification , Adiponectin/genetics , Adiponectin/physiology , Amino Acid Sequence , Collagen Type X/physiology , Evolution, Molecular , Humans , Molecular Sequence Data , Protein Structure, Tertiary/genetics , Protein Structure, Tertiary/physiology , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL